Aeglea BioTherapeutics Receives FDA Fast Track Designation for AEB1102 for the Treatment of Patients with Hyperargininemia Secondary to Arginase I Deficiency
May 23, 2016 16:00 ET
|
Aeglea Biotherapeutics
AUSTIN, Texas, May 23, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid...
Aeglea BioTherapeutics To Present at the UBS 2016 Global Healthcare Conference
May 20, 2016 16:00 ET
|
Aeglea Biotherapeutics
AUSTIN, Texas, May 20, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid...
Aeglea BioTherapeutics Announces First Quarter 2016 Financial Results
May 19, 2016 06:00 ET
|
Aeglea Biotherapeutics
AUSTIN, Texas, May 19, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid...
Aeglea BioTherapeutics Names Dr. Sandra Rojas-Caro as Chief Medical Officer
May 16, 2016 08:00 ET
|
Aeglea Biotherapeutics
AUSTIN, Texas, May 16, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid...
Aeglea BioTherapeutics to Present New Data at American Association for Cancer Research (AACR) Annual Meeting
April 19, 2016 09:00 ET
|
Aeglea Biotherapeutics
AUSTIN, Texas, April 19, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid...
Aeglea BioTherapeutics to Present New Data at American Association for Cancer Research (AACR) Annual Meeting
April 18, 2016 09:00 ET
|
Aeglea Biotherapeutics
AUSTIN, Texas, April 18, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid...
Aeglea BioTherapeutics Announces Closing of Initial Public Offering and Partial Exercise of the Underwriters’ Option
April 12, 2016 16:00 ET
|
Aeglea Biotherapeutics
AUSTIN, Texas, April 12, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid...
Inc. Unveils Its Annual Exclusive List of America's Fastest-Growing Private Companies
August 20, 2013 13:08 ET
|
Inc.
New York, Aug. 20, 2013 (GLOBE NEWSWIRE) -- Inc., the only major business media brand aimed solely
at business owners, has unveiled its annual exclusive lists of the
fastest-growing private companies...
Inc. Magazine announces 2nd annual Hire Power Awards Program
July 11, 2013 10:26 ET
|
Inc.
New York, July 11, 2013 (GLOBE NEWSWIRE) --
Inc. Magazine and Bank of America
Merrill Lynch are proud to recognize American companies that have
greatly increased their workforces. ...
The Creators of the Inc. 5000 Introduce a New Business Index Recognizing America's Enduring Job Creators -- The Build 100
July 02, 2013 11:01 ET
|
Inc.
New York, July 2, 2013 (GLOBE NEWSWIRE) -- What is the only statistically significant predictor of a
company's future success? It's not location, industry, or huge
bursts of growth. Rigorous economic...